TipRanks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market
EMMA
Emmaus Life Sciences
RESEARCH TOOLSreports
Want to see EMMA full AI Analyst Report?

Emmaus Life Sciences (EMMA) Ratios

88 Followers

Emmaus Life Sciences Ratios

EMMA's free cash flow for Q2 2026 was $0.95. For the 2026 fiscal year, EMMA's free cash flow was decreased by $ and operating cash flow was $0.60. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Jun 24Dec 22
Liquidity Ratios
Current Ratio
 0.09 0.11 0.11 0.19 0.12
Quick Ratio
 0.07 0.09 0.08 0.16 0.07
Cash Ratio
 0.04 0.03 0.02 0.04 0.04
Solvency Ratio
 -0.07 -0.09 -0.08 -0.04 -0.13
Operating Cash Flow Ratio
 0.06 >-0.01 -0.04 -0.02 -0.09
Short-Term Operating Cash Flow Coverage
 0.15 >-0.01 -0.08 -0.05 -0.21
Net Current Asset Value
$ -76.54M$ -77.30M$ -73.31M$ -71.43M$ -76.03M
Leverage Ratios
Debt-to-Assets Ratio
 1.86 1.52 1.40 0.93 0.64
Debt-to-Equity Ratio
 -0.46 -0.51 -0.58 -0.68 -0.90
Debt-to-Capital Ratio
 -0.86 -1.05 -1.40 -2.16 -9.42
Long-Term Debt-to-Capital Ratio
 -0.04 -0.04 -0.04 -0.05 -0.12
Financial Leverage Ratio
 -0.25 -0.34 -0.42 -0.74 -1.41
Debt Service Coverage Ratio
 0.08 >-0.01 -0.03 0.10 -0.19
Interest Coverage Ratio
 0.57 0.03 -0.34 0.48 -1.31
Debt to Market Cap
 6.75 37.00 55.30 5.63 2.14
Interest Debt Per Share
 0.55 0.62 0.61 0.75 0.72
Net Debt to EBITDA
 8.15 -98.17 -34.70 8.31 -5.24
Profitability Margins
Gross Profit Margin
93.60%93.12%92.79%95.47%85.93%
EBIT Margin
21.60%-2.80%-5.60%12.13%-30.19%
EBITDA Margin
21.89%-2.49%-5.46%12.24%-29.90%
Operating Profit Margin
29.29%1.85%-11.37%11.96%-35.81%
Pretax Profit Margin
-34.93%-60.09%-38.58%-12.81%-57.45%
Net Profit Margin
-38.79%-60.16%-38.75%-12.61%-57.78%
Continuous Operations Profit Margin
-38.78%-60.16%-38.75%-12.61%-57.78%
Net Income Per EBT
111.04%100.12%100.45%98.44%100.57%
EBT Per EBIT
-119.28%-3239.39%339.18%-107.12%160.42%
Return on Assets (ROA)
-36.80%-34.95%-27.34%-10.61%-22.03%
Return on Equity (ROE)
9.37%11.78%11.43%7.82%31.17%
Return on Capital Employed (ROCE)
-9.14%-0.48%4.74%-13.45%108.00%
Return on Invested Capital (ROIC)
-19.98%-1.23%18.84%154.41%-35.71%
Return on Tangible Assets
-36.80%-34.95%-27.34%-10.61%-22.03%
Earnings Yield
-139.10%-899.94%-1200.56%-70.24%-82.56%
Efficiency Ratios
Receivables Turnover
 21.90 4.44 6.35 5.36 49.04
Payables Turnover
 0.23 0.21 0.36 1.04 8.60
Inventory Turnover
 0.63 0.55 0.73 0.78 1.09
Fixed Asset Turnover
 17.37 14.17 10.57 12.35 6.40
Asset Turnover
 0.95 0.58 0.71 0.84 0.38
Working Capital Turnover Ratio
 -0.25 -0.21 -0.31 -0.60 -0.48
Cash Conversion Cycle
 -996.45 -973.63 -450.04 182.08 300.51
Days of Sales Outstanding
 16.66 82.19 57.49 68.12 7.44
Days of Inventory Outstanding
 583.49 662.28 496.90 465.36 335.52
Days of Payables Outstanding
 1.60K 1.72K 1.00K 351.40 42.45
Operating Cycle
 600.15 744.47 554.39 533.49 342.97
Cash Flow Ratios
Operating Cash Flow Per Share
 0.06 >-0.01 -0.04 -0.03 -0.10
Free Cash Flow Per Share
 0.06 >-0.01 -0.04 -0.03 -0.10
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.09 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 1.98K -11.00 -190.50 -88.41 -195.12
Capital Expenditure Coverage Ratio
 1.98K -11.00 -190.50 -88.41 -195.12
Operating Cash Flow Coverage Ratio
 0.13 >-0.01 -0.07 -0.05 -0.16
Operating Cash Flow to Sales Ratio
 0.26 >-0.01 -0.14 -0.05 -0.28
Free Cash Flow Yield
91.56%-1.44%-427.54%-28.60%-39.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.66 -0.11 -0.09 -1.42 -1.21
Price-to-Sales (P/S) Ratio
 0.28 0.07 0.03 0.18 0.70
Price-to-Book (P/B) Ratio
 -0.07 -0.01 >-0.01 -0.11 -0.38
Price-to-Free Cash Flow (P/FCF) Ratio
 1.09 -69.38 -0.23 -3.50 -2.52
Price-to-Operating Cash Flow Ratio
 1.09 -75.68 -0.24 -3.54 -2.54
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 >-0.01 0.02 0.04
Price-to-Fair Value
 -0.07 -0.01 >-0.01 -0.11 -0.38
Enterprise Value Multiple
 9.43 -100.85 -35.29 9.78 -7.58
Enterprise Value
 32.05M 31.26M 32.11M 35.42M 41.67M
EV to EBITDA
 9.43 -100.85 -35.29 9.78 -7.58
EV to Sales
 2.06 2.51 1.93 1.20 2.27
EV to Free Cash Flow
 8.08 -2.61K -13.97 -23.30 -8.17
EV to Operating Cash Flow
 8.08 -2.84K -14.05 -23.56 -8.21
Tangible Book Value Per Share
 -0.94 -0.99 -0.89 -0.90 -0.69
Shareholders’ Equity Per Share
 -0.94 -0.99 -0.89 -0.90 -0.69
Tax and Other Ratios
Effective Tax Rate
 -0.11 >-0.01 >-0.01 0.02 >-0.01
Revenue Per Share
 0.22 0.19 0.26 0.56 0.37
Net Income Per Share
 -0.09 -0.12 -0.10 -0.07 -0.21
Tax Burden
 1.11 1.00 1.00 0.98 1.01
Interest Burden
 -1.62 21.44 6.89 -1.06 1.90
Research & Development to Revenue
 0.02 0.03 0.04 0.04 0.09
SG&A to Revenue
 0.63 0.89 1.00 0.50 0.72
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.02 0.04 <0.01
Income Quality
 -0.66 <0.01 0.35 0.40 0.48
Currency in USD